Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus.

John P H Wilding,Una Rigney,Betina T Blak,Stephen T Nolan,Peter Fenici,Jesús Medina

Diabetes Research and Clinical Practice（2019）

引用 9|浏览21

暂无评分

摘要

•Of 3774 patients with T2DM from the UK CPRD, 25.2% were early dapagliflozin users.•A higher likelihood of achieving HbA1c goals was seen with early dapagliflozin use.•These data support earlier use of dapagliflozin in the treatment pathway.

查看译文

关键词

Clinical Practice Research Datalink,Dapagliflozin,Early treatment,Treatment intensification,T2DM,Type 2 diabetes mellitus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要